134 results
8-K
EX-99.2
7ge66rb
8 Jan 24
Mirum Pharmaceuticals Announces Preliminary Unaudited 2023 Net Revenue and Provides Corporate Updates
8:30am
424B5
aapumvb70 ukc1mzz1k2
2 Nov 23
Prospectus supplement for primary offering
4:59pm
8-K/A
EX-99.4
7611pbg8ga5xq0 ona
2 Nov 23
Financial Statements and Exhibits
4:05pm
8-K/A
EX-99.3
g0kf6wflow8g0j3
2 Nov 23
Financial Statements and Exhibits
4:05pm
S-3ASR
7cv81xqrxvt5l4ni
13 Oct 23
Automatic shelf registration
4:47pm
8-K
EX-99.1
t7rw1ly6si16swo8zt
13 Oct 23
Other Events
4:16pm
8-K
EX-10.1
392o1a5
11 Sep 23
Departure of Directors or Certain Officers
4:16pm
8-K
EX-99.1
j9a3d
5 Sep 23
Mirum Pharmaceuticals Completes Acquisition of Bile Acid Product Portfolio for Treatment of Rare Liver Diseases from Travere Therapeutics
8:36am
8-K
ubtz1dt
30 Aug 23
Departure of Directors or Certain Officers
4:15pm
8-K
EX-10.1
z219x2x2 f9z
30 Aug 23
Departure of Directors or Certain Officers
4:15pm